Response to letter: "Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease"

Affiliations

¹ Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain; Radiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
² Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain.
³ Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain. Electronic address: jkulisevsky@santpau.cat.

Comment

Frederic Sampedro et al. J Neurol Sci. 2022.

. 2022 Jul 15:438:120272.

doi: 10.1016/j.jns.2022.120272. Epub 2022 May 2.

¹ Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain; Radiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
² Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain.
³ Movement Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Biomedical Research Institute (IIB-Sant Pau), Barcelona, Spain; Centro de Investigación en Red-Enfermedades Neurodegenerativas (CIBERNED), Spain. Electronic address: jkulisevsky@santpau.cat.

No abstract available

Keywords: Cognitive impairment; Homocysteine; Parkinson's disease.

Comment on

Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease.
Sampedro F, Martínez-Horta S, Horta-Barba A, Grothe MJ, Labrador-Espinosa MA, Jesús S, Adarmes-Gómez A, Carrillo F, Puig-Davi A, Lora FR, Barberá MA, Pastor P, Arroyo SE, Vila BS, Foraster AC, Martínez JR, Padilla FC, Morlans MP, Aramburu IG, Ceberio JI, Vara JH, de Fábregues-Boixar O, de Deus Fonticoba T, Ávila A, Martínez-Castrillo JC, Bejr-Kasem H, Campolongo A, Pascual-Sedano B; COPPADIS Study Group; Martínez-Martín P, Santos-García D, Mir P, Kulisevsky J. Sampedro F, et al. J Neurol Sci. 2022 Mar 15;434:120148. doi: 10.1016/j.jns.2022.120148. Epub 2022 Jan 12. J Neurol Sci. 2022. PMID: 35085959
Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease.
Christine CW, Green R. Christine CW, et al. J Neurol Sci. 2022 Mar 15;434:120185. doi: 10.1016/j.jns.2022.120185. Epub 2022 Feb 12. J Neurol Sci. 2022. PMID: 35180679 No abstract available.